1. Maeda T, Tateishi U, Hasegawa T, Ojima H, Arai Y, Sugimura K. Primary hepatic angiosarcoma on coregistered FDG PET and CT images. AJR Am J Roentgenol 2007;188(6):1615-1617. [Abstract]
2. Arribas-Garcia I, Dominguez MF, Alcala-Galiano A, Garcia AF, Vals JC, De Rasche EN. Oral primary angiosarcoma of the lower lip mucosa: Report of a case in a 15-year-old boy. Head Neck 2008;30(10):1384-1388. [Abstract]
3. Penel N, Van Haverbeke C, Lartigau E, Vilain MO, Ton Van J, Mallet Y, Lefebvre JL. Head and neck soft tissue sarcomas of adult: prognostic value of surgery in multimodal therapeutic approach. Oral Oncol 2004;40(9):890-897. [Abstract]
4. Fedok FG, Levin RJ, Maloney ME, Tipirneni K. Angiosarcoma: current review. Am J Otolaryngol 1999;20(4):223-231. [Abstract]
5. Meis-Kindblom JM, Kindblom LG. Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol 1998;22(6):683-697. [Abstract]
6. Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, Townsend DW, Berland LL, Parker JA, Hubner K, Stabin MG, Zubal G, Kachelriess M, Cronin V, Holbrook S. Procedure guideline for tumor imaging with F-18 FDG PET/CT. J Nucl Med 2006;47(5):885-895. [Abstract]
7. Hori Y, Funabashi N, Miyauchi H, Nakagawa K, Shimura H, Miyazaki M, Kozono H, Nagai Y, Ishikura H, Nagai T, Kobayashi Y, Komuro I. Angiosarcoma in the right atria demonstrated by fusion images of multislice computed tomography and positron emission tomography using F-18 Fluoro-Deoxyglucose. Int J Cardiol 2007;123(1):15-17. [Abstract]
8. Freudenberg LS, Rosenbaum SJ, Schulte-Herbrüggen J, Eising EG, Lauenstein T, Wolff A, Bockisch A. Diagnosis of a cardiac angiosarcoma by fluorine-18 fluordeoxyglucose positron emission tomography. Eur Radiol 2002;12(3):158-161. [Abstract]
9. Oe A, Habu D, Kawabe J, Torii K, Kawamura E, Kotani J, Hayashi T, Sakaguchi H, Shiomi S. A case of diffuse hepatic angiosarcoma diagnosed by FDG-PET. Ann Nucl Med 2005;19(6):519-521. [Abstract]
10. Lin E. Diagnosis of venous angiosarcoma by FDG PET/CT. Clin Nucl Med 2008;33(1):66-67. [Abstract]
11. Vasanawala MS, Wang Y, Quon A, Gambhir SS. F-18 fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp. Clin Nucl Med 2006;31(9):534-537. [Abstract]
12. Lucas JD, O'Doherty MJ, Wong JC, Bingham JB, McKee PH, Fletcher CD, Smith MA. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. J Bone Joint Surg Br 1998;80(3):441-447. [Abstract]
13. Jones DN, McCowage GB, Sostman HD, Brizel DM, Layfield L, Charles HC, Dewhirst MW, Prescott DM, Friedman HS, Harrelson JM, Scully SP, Coleman RE. Monitoring of Neoadjuvant Therapy Response of Soft-tissue and Musculoskeletal Sarcoma Using Fluorine-18-FDG PET. J Nucl Med 1996;37(9):1438-1444. [Abstract]
14. Pestoni C, Paredes-Suarez C, Peteiro C, Toribio J. Early detection of cutaneous angiosarcoma of the face and scalp and treatment with placitaxel. J Eur Acad Dermatol Venereol 2005;19(3): 357-359. [Abstract]
15. Evilevitch V, Weber WA, Tap WD, Allen-Auerbach M, Chow K, Nelson SD, Nelson SD, Eilber FR, Eckardt JJ, Elashoff RM, Phelps ME, Czernin J, Eilber FC. Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft tissue sarcomas. Clin Cancer Res 2008;14(3):715-718. [Abstract]
16. Kasper B, Hohenberger P, Strauss LG, Dimitrakopoulou-Strauss A. The use of fluorine-18 fluorodeoxyglucose-positron emission tomography for treatment monitoring in patients with soft tissue sarcomas. Hell J Nucl Med 2010;13(1):40-44. [Abstract]